155 related articles for article (PubMed ID: 23960742)
1. The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia.
Alsultan MS
Saudi Pharm J; 2011 Jan; 19(1):51-6. PubMed ID: 23960742
[TBL] [Abstract][Full Text] [Related]
2. The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations.
Al Aqeel SA; Al-Sultan M
Saudi Pharm J; 2012 Jul; 20(3):187-94. PubMed ID: 23960792
[TBL] [Abstract][Full Text] [Related]
3. Use of pharmacoeconomic data in making hospital formulary decisions.
Odedina FT; Sullivan J; Nash R; Clemmons CD
Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
[TBL] [Abstract][Full Text] [Related]
4. Barriers to implementing pharmacoeconomics: interview study.
Alefan Q; Hamdouni E; Alhamad H; Mukattash T; Rascati K
Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):93-104. PubMed ID: 32394752
[No Abstract] [Full Text] [Related]
5. Pharmacoeconomics and formulary decision making.
Sanchez LA
Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
[TBL] [Abstract][Full Text] [Related]
6. Hospital pharmacy practice in Saudi Arabia: Prescribing and transcribing in the Riyadh region.
Alsultan MS; Khurshid F; Salamah HJ; Mayet AY; Al-Jedai AH
Saudi Pharm J; 2012 Jul; 20(3):203-10. PubMed ID: 23960794
[TBL] [Abstract][Full Text] [Related]
7. Attitude and perception of pharmacists and healthcare professionals about the criteria used in drug formulary selection in the United Arab Emirates.
Al-Hemyari SS; Mohamed Noor DA; El-Dahiyat F
J Pharm Policy Pract; 2022 Oct; 15(1):67. PubMed ID: 36258258
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Training, Responsibilities, and Practices of P&T Committee Members and Nonmember Contributors.
Rodriguez R; Kelly BJ; Moody M
J Manag Care Spec Pharm; 2017 Aug; 23(8):868-874. PubMed ID: 28737984
[TBL] [Abstract][Full Text] [Related]
9. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees.
Anell A; Svarvar P
Pharmacoeconomics; 2000 Feb; 17(2):175-85. PubMed ID: 10947340
[TBL] [Abstract][Full Text] [Related]
11. Management of Hospital Formularies in Ontario: Challenges within a Local Health Integration Network.
Burke N; Bowen JM; Troyan S; Jegathisawaran J; Gosse C; Tonkin M; Kagoma S; Goeree R; Holbrook A
Can J Hosp Pharm; 2016; 69(3):187-93. PubMed ID: 27402997
[TBL] [Abstract][Full Text] [Related]
12. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
Matlala M; Gous AG; Godman B; Meyer JC
Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
[TBL] [Abstract][Full Text] [Related]
13. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
Mittmann N; Knowles S
Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Presence of Cognitive Biases in Health Care Decision Making: A Survey of U.S. Formulary Decision Makers.
Mezzio DJ; Nguyen VB; Kiselica A; O'Day K
J Manag Care Spec Pharm; 2018 Nov; 24(11):1173-1183. PubMed ID: 30362919
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic education in Egyptian schools of pharmacy.
Soliman AM; Hussein M; Abdulhalim AM
Am J Pharm Educ; 2013 Apr; 77(3):57. PubMed ID: 23610475
[TBL] [Abstract][Full Text] [Related]
16. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
[TBL] [Abstract][Full Text] [Related]
17. Knowledge, attitude and dispensing practice of the pharmacists related to complementary alternative medicines in the Riyadh region of Saudi Arabia: a cross-sectional descriptive study.
Al-Yousef HM; Alghadir AH; Iqbal A
BMC Health Serv Res; 2022 Dec; 22(1):1533. PubMed ID: 36527035
[TBL] [Abstract][Full Text] [Related]
18. Application of pharmacoeconomics to formulary decision making in managed care organizations.
Suh DC; Okpara IR; Agnese WB; Toscani M
Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
[TBL] [Abstract][Full Text] [Related]
19. The pharmacoeconomic picture in Saudi Arabia.
Alkhenizan A
Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):483-90. PubMed ID: 24953076
[TBL] [Abstract][Full Text] [Related]
20. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
Segal R; Pathak DS
Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
